JP2002531055A5 - - Google Patents

Download PDF

Info

Publication number
JP2002531055A5
JP2002531055A5 JP2000562519A JP2000562519A JP2002531055A5 JP 2002531055 A5 JP2002531055 A5 JP 2002531055A5 JP 2000562519 A JP2000562519 A JP 2000562519A JP 2000562519 A JP2000562519 A JP 2000562519A JP 2002531055 A5 JP2002531055 A5 JP 2002531055A5
Authority
JP
Japan
Prior art keywords
protein
determining whether
proteins
potential
antimicrobial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000562519A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002531055A (ja
Filing date
Publication date
Priority claimed from GBGB9816337.1A external-priority patent/GB9816337D0/en
Application filed filed Critical
Priority claimed from PCT/GB1999/002451 external-priority patent/WO2000006737A2/en
Publication of JP2002531055A publication Critical patent/JP2002531055A/ja
Publication of JP2002531055A5 publication Critical patent/JP2002531055A5/ja
Pending legal-status Critical Current

Links

JP2000562519A 1998-07-27 1999-07-27 肺炎連鎖球菌のタンパク質及び核酸分子 Pending JP2002531055A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9816337.1A GB9816337D0 (en) 1998-07-27 1998-07-27 Proteins
US12516499P 1999-03-19 1999-03-19
US60/125,164 1999-03-19
US9816337.1 1999-03-19
PCT/GB1999/002451 WO2000006737A2 (en) 1998-07-27 1999-07-27 Streptococcus pneumoniae proteins and nucleic acid molecules

Related Child Applications (5)

Application Number Title Priority Date Filing Date
JP2008080923A Division JP2008263968A (ja) 1998-07-27 2008-03-26 肺炎連鎖球菌のタンパク質及び核酸分子
JP2008081183A Division JP2008263969A (ja) 1998-07-27 2008-03-26 肺炎連鎖球菌のタンパク質及び核酸分子
JP2008081417A Division JP2008263970A (ja) 1998-07-27 2008-03-26 肺炎連鎖球菌のタンパク質及び核酸分子
JP2008080545A Division JP2008263966A (ja) 1998-07-27 2008-03-26 肺炎連鎖球菌のタンパク質及び核酸分子
JP2009035978A Division JP2009148283A (ja) 1998-07-27 2009-02-19 肺炎連鎖球菌のタンパク質及び核酸分子

Publications (2)

Publication Number Publication Date
JP2002531055A JP2002531055A (ja) 2002-09-24
JP2002531055A5 true JP2002531055A5 (https=) 2010-02-25

Family

ID=26314125

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2000562519A Pending JP2002531055A (ja) 1998-07-27 1999-07-27 肺炎連鎖球菌のタンパク質及び核酸分子
JP2008081183A Pending JP2008263969A (ja) 1998-07-27 2008-03-26 肺炎連鎖球菌のタンパク質及び核酸分子
JP2008080923A Pending JP2008263968A (ja) 1998-07-27 2008-03-26 肺炎連鎖球菌のタンパク質及び核酸分子
JP2008080545A Pending JP2008263966A (ja) 1998-07-27 2008-03-26 肺炎連鎖球菌のタンパク質及び核酸分子
JP2008081417A Pending JP2008263970A (ja) 1998-07-27 2008-03-26 肺炎連鎖球菌のタンパク質及び核酸分子
JP2009035978A Pending JP2009148283A (ja) 1998-07-27 2009-02-19 肺炎連鎖球菌のタンパク質及び核酸分子

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2008081183A Pending JP2008263969A (ja) 1998-07-27 2008-03-26 肺炎連鎖球菌のタンパク質及び核酸分子
JP2008080923A Pending JP2008263968A (ja) 1998-07-27 2008-03-26 肺炎連鎖球菌のタンパク質及び核酸分子
JP2008080545A Pending JP2008263966A (ja) 1998-07-27 2008-03-26 肺炎連鎖球菌のタンパク質及び核酸分子
JP2008081417A Pending JP2008263970A (ja) 1998-07-27 2008-03-26 肺炎連鎖球菌のタンパク質及び核酸分子
JP2009035978A Pending JP2009148283A (ja) 1998-07-27 2009-02-19 肺炎連鎖球菌のタンパク質及び核酸分子

Country Status (5)

Country Link
EP (2) EP1100921B1 (https=)
JP (6) JP2002531055A (https=)
AT (1) ATE361365T1 (https=)
DE (1) DE69935986D1 (https=)
WO (1) WO2000006737A2 (https=)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800744B1 (en) 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
ES2322306T3 (es) * 1998-12-21 2009-06-18 Medimmune, Inc. Proteinas de streptpcpccus pneumoniae y fragmentos inmunogenicos para vacunas.
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
EP1950302B1 (en) 1998-12-23 2012-12-05 ID Biomedical Corporation of Quebec Streptococcus antigens
ES2400280T3 (es) * 1998-12-23 2013-04-08 Id Biomedical Corporation Of Quebec Antígenos de estreptococos
EP1075841A1 (en) * 1999-08-13 2001-02-14 Erasmus Universiteit Rotterdam Pneumococcal vaccines
AU2001270381B2 (en) * 2000-06-20 2007-05-24 Id Biomedical Corporation Streptococcus antigens
US7074415B2 (en) 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
US7892552B2 (en) 2001-08-08 2011-02-22 University Of Utah Research Foundation Group B Streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
PT1320542E (pt) 2000-08-08 2007-08-06 St Jude Childrens Res Hospital Ácidos nucleicos de estreptococo de grupo b, polipéptidos, composições terapêuticas e vacinas correspondentes
DK1328543T3 (da) 2000-10-27 2009-11-23 Novartis Vaccines & Diagnostic Nukleinsyrer og proteiner fra streptococcus-gruppe A & B
EP1343895B1 (en) 2000-12-21 2008-06-18 ID Biomedical Corporation Streptococcus pyogenes antigens and corresponding dna fragments
GB0107658D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
EP1456231A2 (en) 2001-12-20 2004-09-15 Shire Biochem Inc. Streptococcus antigens
ES2451620T3 (es) * 2002-11-07 2014-03-28 Synergy America, Inc. Composiciones y métodos destinados a tratar o prevenir la infección neumocócica
EP2333114A1 (en) * 2003-04-15 2011-06-15 Intercell AG S. pneumoniae antigens
JP4875490B2 (ja) 2003-07-31 2012-02-15 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｙｏｇｅｎｅｓについての免疫原組成物
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
CA2545325C (en) * 2003-11-10 2015-01-13 Uab Research Foundation Compositions for reducing bacterial carriage and cns invasion and methods of using same
AU2007285775B2 (en) 2006-08-17 2011-03-03 Sanofi Pasteur Ltd. Immunogenic PcpA polypeptides and uses thereof
US8722055B2 (en) * 2006-09-27 2014-05-13 St. Jude Children's Research Hospital Synthetic Streptococcus pneumoniae vaccine
EP2450054B1 (en) * 2007-04-12 2018-07-18 Stichting Katholieke Universiteit New virulence factors of Streptococcus pneumoniae
US8329195B2 (en) 2007-05-23 2012-12-11 The Uab Research Foundation Detoxified pneumococcal neuraminidase and uses thereof
GB0714963D0 (en) 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
CA2699513C (en) 2007-09-12 2018-03-13 Novartis Ag Gas57 mutant antigens and gas57 antibodies
PT2268618E (pt) 2008-03-03 2015-10-12 Novartis Ag Compostos e composições moduladores da actividade tlr
CA2765112A1 (en) 2009-06-10 2010-12-16 Novartis Ag Benzonaphthyridine-containing vaccines
JO3257B1 (ar) 2009-09-02 2018-09-16 Novartis Ag مركبات وتركيبات كمعدلات لفاعلية tlr
ES2443952T3 (es) 2009-09-02 2014-02-21 Novartis Ag Composiciones inmunógenas que incluyen moduladores de la actividad de TLR
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
SG10201501980SA (en) 2009-12-15 2015-05-28 Novartis Ag Homogeneous suspension of immunopotentiating compounds and uses thereof
WO2011105891A1 (en) 2010-02-23 2011-09-01 Stichting Katholieke Universiteit, More Particularly The Radboud University Nijmegen Medical Centre Combination vaccine for streptococcus
EP2550289A4 (en) 2010-03-12 2013-11-27 Childrens Medical Center NEW IMMUNOGENES AND METHODS FOR IDENTIFICATION AND SCREENING THEREOF
AU2011232421B2 (en) 2010-03-23 2015-08-13 Novartis Ag Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc.
JP2015510872A (ja) 2012-03-07 2015-04-13 ノバルティス アーゲー Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ抗原の増強された製剤
JP6411378B2 (ja) 2013-02-01 2018-10-24 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム Ｔｏｌｌ様受容体アゴニストを含む免疫学的組成物の皮内送達
JP6494527B2 (ja) 2013-02-07 2019-04-03 ザ チルドレンズ メディカル センター コーポレーション 肺炎球菌のコロニー形成および／または疾患からの保護を提供するタンパク質抗原
GB201509782D0 (en) * 2015-06-05 2015-07-22 Isis Innovation Methods and products for fusion protein synthesis
ES2985591T3 (es) 2018-02-12 2024-11-06 Inimmune Corp Ligandos de receptores tipo Toll
IL281204B2 (en) 2018-09-12 2025-07-01 Affinivax Inc Multivalent pneumococcal vaccines
KR20230098825A (ko) 2020-11-04 2023-07-04 엘리고 바이오사이언스 씨. 아크네스 개체군에게 dna 페이로드의 원위치 전달을 위한 파지-유래 입자
IL326005A (en) 2021-09-09 2026-03-01 Affinivax Inc Multivalent pneumococcal vaccines

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980909A (en) * 1991-02-15 1999-11-09 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
CA2116261A1 (en) * 1993-04-20 1994-10-21 David E. Briles Epitopic regions of pneumococcal surface protein a
US5928900A (en) * 1993-09-01 1999-07-27 The Rockefeller University Bacterial exported proteins and acellular vaccines based thereon
EP0956289A4 (en) * 1996-08-16 2004-10-13 Smithkline Beecham Corp NOVEL PROKARYOTA POLYNUCLEOTIDES AND POLYPEPTIDES AND USES THEREOF
JP4469026B2 (ja) * 1996-10-31 2010-05-26 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド Ｓｔｒｅｐｔｏｃｏｃｃｕｓ ｐｎｅｕｍｏｎｉａｅの抗原およびワクチン
EP0885966A3 (en) * 1997-06-20 1999-12-29 Smithkline Beecham Corporation Novel compouds
EP0891984A3 (en) * 1997-06-20 2000-01-19 Smithkline Beecham Corporation Nucleic acid encoding streptococcus pneumoniae response regulator
EP1783224A3 (en) * 1998-07-27 2007-08-15 Sanofi Pasteur Limited Streptococcus pneumoniae proteins and nucleic acid molecules

Similar Documents

Publication Publication Date Title
JP2002531055A5 (https=)
IL128727A0 (en) Angiogenic factor and use thereof in treating cardiovascular disease
DE60040060D1 (de) Kontrolle des proteinspiegels in eukaryotischen organismen
PT749317E (pt) Aplicacoes terapeuticas de produtos dimericos de proteinas bactericidas indutoras da permeabilidade
EP1764370A3 (en) Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2
ATE364698T1 (de) Neues, physiologisch aktives peptid und dessen verwendung
WO1998049300A3 (en) Truncated vegf-related proteins
EP0909814A3 (en) Use of protein kinases for the diagnosis and treatment of Alzheimer's disease
ATE406383T1 (de) Verkürzte tau proteine
CA2105304A1 (en) Inhibitors of human neutrophil elastase and human cathepsin g
CA2034504A1 (en) Fungal stress proteins
DE69838544D1 (de) Isolierung von gewebspezifischen peptidliganden und ihre verwendung zur ausrichtung von pharmazeutika auf zielorgane
PT1126870E (pt) Utilizacao do gene vegf-c ou vegf-d ou de uma proteina na prevencao da restenose
DK0750672T3 (da) DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse
WO2004074486A3 (en) Fusion proteins of interferon alpha muteins with improved properties
WO2002077176A3 (en) Aberrantly expressed proteins in laser capture microdissected tumors
WO2005026205A3 (de) Differentiell in tumoren exprimierte genprodukte und deren verwendung
IT1270618B (it) Proteine ad attivita' antitumorale
WO2003070889A3 (en) Prostate specific genes and the use thereof in design or therapeutics
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
WO2001007479A3 (en) Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases
WO2001034640A3 (de) Humanes zirkulierendes virus inhibierendes peptid (virip) und seine verwendung
NO995692D0 (no) Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse
WO2003006630A3 (en) Nucleic acid free ghost preparations
AR024483A1 (es) Proteinas insecticidas y nematocidas